Ironwood Pharmaceuticals to Acquire VectivBio for About $1 Billion
Ironwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about $1 billion
6 Underperforming IPO Stocks To Buy On The Dip
Two Biotechs Are Set to Start Trading Today